BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Biocon Biologics Settles with Janssen to Launch Biosimilar Bmab 1200 Across Key Markets August 30, 2024 The agreement resolves patent disputes and sets market entry dates for Bmab 1200 in these regions, according to a stock exchange filing by Biocon.
Recursion Pharmaceuticals to Acquire Exscientia in $688 Mn All-Stock Deal August 12, 2024 The deal, anticipated to close in early 2025, will equip the combined entity with approximately $850 million in cash, supporting its operations for the next three years.
Agilent Technologies to Acquire Biovectra for $925 Mn July 25, 2024 Upon completion, Biovectra will become part of the Agilent Diagnostics and Genomics Group.
Pharma M&A: Big Deals of Early 2024 July 6, 2024 This article delves into the noteworthy acquisition deals that have defined the first half of the year
Pharma Giants GSK, Moderna, Novartis & Others Form Consortium to Manage Biospecimen for Clinical Trials June 27, 2024 This coalition aims to address and rectify inefficiencies in the biospecimen management lifecycle, starting with a comprehensive industry survey to assess current practices.
Pharma Giant Bayer AG Slashes 1500 Headcount Facing Decreased Sales May 15, 2024 The job cut affected primarily the management vertical, coinciding with a slight sales decline and a revised full-year earnings forecast.
Top Pharma Acquisitions Looking at Closure in 2024 April 6, 2024 The first quarter of 2024 witnessed several acquisitions, while many of the deals from 2023 are still awaiting closure. Let’s now take a closer look at the pharmaceutical deals that we anticipate will be finalized by 2024.
AstraZeneca to Acquire Amolyt Pharma for $1.05 Bn to Boost Rare-Disease Portfolio March 15, 2024 This acquisition of Amolyt backed by EQT Life Sciences is expected to strengthen Alexion, AstraZeneca's rare disease arm.
Govt Rolls Out Uniform Code for Pharmaceutical Marketing Practices 2024 March 14, 2024 Led by the Ministry of Chemicals and Fertilizers, this initiative aims to address misleading promotional activities and promote responsible marketing within the pharmaceutical sector.
Factors that Drove the Growth of API Biz in 2023 December 31, 2023 This year has witnessed a remarkable surge in the API business, driven by multifaceted factors that have reshaped the global pharmaceutical landscape.
Top Acquisitions that Hit The Pharma Industry in 2023 December 28, 2023 At the heart of this transformative journey were the noteworthy acquisitions that left an indelible mark on the pharma landscape. Let's take a closer look at some of the top acquisitions that shaped the pharma sector in 2023.
Bristol Myers to Buy Karuna Therapeutics for $14 Bn to Bolster Neuro Portfolio December 27, 2023 This strategic acquisition fits squarely with Briston’s business development priorities of pursuing assets that are strategically aligned, scientifically sound, financially attractive, and have the potential to address areas of significant unmet medical need.
